Literature DB >> 11146044

Magnetic resonance imaging applications in the evaluation of tumor angiogenesis.

M Neeman1, J M Provenzale, M W Dewhirst.   

Abstract

Angiogenesis, the growth of new blood vessels, is a critical component in the development of solid tumors. Over the last decade, progress in the study of the biology of angiogenesis has led to identification of a large number of molecules that promote, participate, and regulate the growth of new vessels in normal tissue and in tumors. Consequently, many new targets for suppression of angiogenesis have been identified and are now at various stages of development and evaluation in clinical trials. Magnetic resonance imaging (MRI) provides an attractive tool for in vivo analysis of the basic biology of angiogenesis, for preclinical evaluation of the activity of a number of potential antiangiogenic agents, as well as for clinical detection, diagnosis, and prognosis. One of the features of MRI is the wide range of physiologic parameters by which angiogenesis can be imaged. This review presents the biological basis of angiogenesis with emphasis on characteristics of the neovasculature that can be used for imaging, followed by an overview of the MRI approaches that are being evaluated for the analysis of tumor angiogenesis. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11146044     DOI: 10.1053/srao.2001.18105

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  6 in total

1.  Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model.

Authors:  Wilfried Reichardt; Dana Hu-Lowe; Denise Torres; Ralph Weissleder; Alexei Bogdanov
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

Review 2.  Visualizing vascular permeability and lymphatic drainage using labeled serum albumin.

Authors:  Katrien Vandoorne; Yoseph Addadi; Michal Neeman
Journal:  Angiogenesis       Date:  2010-05-29       Impact factor: 9.596

3.  High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide.

Authors:  Gregory A Christoforidis; Ming Yang; Marinos S Kontzialis; Douglas G Larson; Amir Abduljalil; Michelle Basso; Weilian Yang; Abhik Ray-Chaudhury; Johannes Heverhagen; Michael V Knopp; Rolf F Barth
Journal:  Invest Radiol       Date:  2009-07       Impact factor: 6.016

4.  Gaussian mixture model-based classification of dynamic contrast enhanced MRI data for identifying diverse tumor microenvironments: preliminary results.

Authors:  S H Han; E Ackerstaff; R Stoyanova; S Carlin; W Huang; J A Koutcher; J K Kim; G Cho; G Jang; H Cho
Journal:  NMR Biomed       Date:  2013-02-25       Impact factor: 4.044

5.  Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101.

Authors:  Fabian Kiessling; Nabeel Farhan; Matthias P Lichy; Silvia Vosseler; Melanie Heilmann; Martin Krix; Peter Bohlen; Dan W Miller; Margareta M Mueller; Wolfhard Semmler; Norbert E Fusenig; Stefan Delorme
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

6.  Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.

Authors:  HyungJoon Cho; Ellen Ackerstaff; Sean Carlin; Mihaela E Lupu; Ya Wang; Asif Rizwan; Joseph O'Donoghue; C Clifton Ling; John L Humm; Pat B Zanzonico; Jason A Koutcher
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.